Consolidated Statements of Operations - USD ($)
$ in Millions |
3 Months Ended |
9 Months Ended |
Nov. 30, 2020 |
Nov. 30, 2019 |
Nov. 30, 2020 |
Nov. 30, 2019 |
| Revenue |
|
|
|
|
| Revenues |
$ 218
|
$ 267
|
$ 683
|
$ 758
|
| Cost of sales |
|
|
|
|
| Cost of sales |
(69)
|
(69)
|
(192)
|
(207)
|
| Gross margin |
149
|
198
|
491
|
551
|
| Operating expenses |
|
|
|
|
| Research and development |
53
|
66
|
167
|
199
|
| Selling, marketing and administration |
83
|
129
|
252
|
380
|
| Amortization |
45
|
49
|
137
|
146
|
| Impairment of goodwill |
0
|
0
|
594
|
0
|
| Impairment of long-lived assets (note 3) |
0
|
3
|
21
|
5
|
| Debentures fair value adjustment |
95
|
(20)
|
114
|
(71)
|
| Total operating expenses |
276
|
227
|
1,285
|
659
|
| Operating loss |
(127)
|
(29)
|
(794)
|
(108)
|
| Investment income (loss), net |
(1)
|
(1)
|
(6)
|
2
|
| Loss before income taxes |
(128)
|
(30)
|
(800)
|
(106)
|
| Provision for (recovery of) income taxes (note 5) |
2
|
2
|
(11)
|
5
|
| Net loss |
$ (130)
|
$ (32)
|
$ (789)
|
$ (111)
|
| Loss per share (note 8) |
|
|
|
|
| Earnings (Loss) Per Share, Basic (in usd per share) |
$ (0.23)
|
$ (0.06)
|
$ (1.41)
|
$ (0.20)
|
| Earnings (Loss) Per Share, Diluted (in usd per share) |
$ (0.23)
|
$ (0.07)
|
$ (1.41)
|
$ (0.27)
|